Supporting patients through opioid analgesic discontinuations
The timelines and alternative options for thousands of patients living with pain when oral morphine and oxycodone are discontinued this year.
New normal for SABA supply has begun
The Schedule 3 entry for salbutamol was updated on 1 October 2023, coinciding with a new treatment guideline around asthma relievers.
Is it still safe to use azithromycin?
The TGA has issued a warning after receiving reports possibly associating azithromycin with cardiovascular death in several patients.
Changes to S3 salbutamol scheduling
Amendments to the S3 listing for salbutamol released last week will ease dispensing restrictions, hopefully reducing patient frustration and stopping unacceptable abuse experienced by some pharmacists.
New migraine treatment approved
The TGA has approved a new preventative treatment for migraine, with a new medicine that targets the calcitonin gene-related peptide receptor.
Patients experiencing migraine will...
Lack of SafeScript use linked to patient’s death
More than 3,000 S8 and diazepam tablets prescribed while RTPM was being largely ignored. While doctors were implicated, 14 pharmacists could have been too.
